Anti-HIV-1 nanotherapeutics: promises and challenges for the future

References

• BruchezMJrMoronneMGinPWeissSAlivisatosAPSemiconductor nanocrystals as fluorescent biological labelsScience19982815385201320169748157
   PubMed Web of Science ®Google Scholar
• ChanWCNieSQuantum dot bioconjugates for ultrasensitive non-isotopic detectionScience19982815385201620189748158
   PubMed Web of Science ®Google Scholar
• PardridgeWMGene targeting in vivo with pegylated immunoliposomesMethods Enzymol200337350752814714424
   PubMed Web of Science ®Google Scholar
• ShiNBoadoRJPardridgeWMReceptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomesPharm Res2001a1881091109511587478
   PubMed Web of Science ®Google Scholar
• ShiNZhangYZhuCBoadoRJPardridgeWMBrain-specific expression of an exogenous gene after i.v. administrationProc Natl Acad Sci U S A23200198221275412759
   Google Scholar
• VinogradovSThe second annual symposium on nanomedicine and drug delivery: exploring recent developments and assessing major advancesAugust 19–20, 2004Polytechnic University, Brooklyn, NY, USAExpert Opin Drug Deliv20041118118416296729
   PubMedGoogle Scholar
• YongKTQianJRoyIQuantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cellsNano Lett20077376176517288490
   PubMed Web of Science ®Google Scholar
• LeeDEKooHSunICRyuJHKimKKwonICMultifunctional nanoparticles for multimodal imaging and theragnosisChem Soc Rev20124172656267222189429
   PubMed Web of Science ®Google Scholar
• LammersTAimeSHenninkWEStormGKiesslingFTheranostic nanomedicineAcc Chem Res201144101029103821545096
   PubMed Web of Science ®Google Scholar
• KimBYRutkaJTChanWCNanomedicineN Engl J Med2010363252434244321158659
   PubMed Web of Science ®Google Scholar
• ParboosingRMaguireGEMGovenderPKrugerHGNanotechnology and the treatment of HIV infectionViruses2012448852022590683
   PubMed Web of Science ®Google Scholar
• ArmsteadALLiBNanomedicine as an emerging approach against intracellular pathogensInt J Nanomedicine201163281329322228996
   PubMed Web of Science ®Google Scholar
• LaraHHGarza-TrevinoENIxtepan-TurrentLSinghDKSilver nanoparticles are broad-spectrum bactericidal and virucidal compoundsJ Nanobiotechnology201193021812950
   PubMed Web of Science ®Google Scholar
• das NevesJAmijiMSarmentoBMucoadhesive nanosystems for vaginal microbicide development: friend or foe?Wiley Interdiscip Rev Nanomed Nanobiotechnol20113438939921506290
   PubMed Web of Science ®Google Scholar
• KimJMHanSHImmunotherapeutic restoration in HIV-infected individualsImmunotherapy20113224726721322762
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCProgress in antiretroviral drug delivery using nanotechnologyInt J Nanomedicine2010553354720957115
   PubMed Web of Science ®Google Scholar
• KimPSReadSWNanotechnology and HIV: potential applications for treatment and preventionWiley Interdiscip Rev Nanomed Nanobiotechnol20102669370220860050
   PubMed Web of Science ®Google Scholar
• ChawlaPChawlaVMaheshwariRSarafSASarafSKFullerenes: from carbon to nanomedicineMini Rev Med Chem201010866267720236059
   PubMed Web of Science ®Google Scholar
• MamoTMosemanEAKolishettiNEmerging nanotechnology approaches for HIV/AIDS treatment and preventionNanomedicine (Lond)20105226928520148638
   PubMed Web of Science ®Google Scholar
• Seale-GoldsmithMMLearyJFNanobiosystemsWiley Interdiscip Rev Nanomed Nanobiotechnol20091555356720049817
   PubMed Web of Science ®Google Scholar
• HauckTSGiriSGaoYChanWCNanotechnology diagnostics for infectious diseases prevalent in developing countriesAdv Drug Deliv Rev2010624–543844819931580
   PubMed Web of Science ®Google Scholar
• WongHLChattopadhyayNWuXYBendayanRNanotechnology applications for improved delivery of antiretroviral drugs to the brainAdv Drug Deliv Rev2010624–550351719914319
   PubMed Web of Science ®Google Scholar
• das NevesJAmijiMMBahiaMFSarmentoBNanotechnology-based systems for the treatment and prevention of HIV/AIDSAdv Drug Deliv Rev2010624–545847719914314
   PubMed Web of Science ®Google Scholar
• GuptaUJainNKNon-polymeric nano-carriers in HIV/AIDS drug delivery and targetingAdv Drug Deliv Rev2010624–547849019913579
   PubMed Web of Science ®Google Scholar
• BoisselierEAstrucDGold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicityChem Soc Rev20093861759178219587967
   PubMed Web of Science ®Google Scholar
• NowacekAGendelmanHENanoART, neuroAIDS and CNS drug deliveryNanomedicine (Lond)20094555757419572821
   PubMed Web of Science ®Google Scholar
• BerryCCIntracellular delivery of nanoparticles via the HIV-1 tat peptideNanomedicine (Lond)20083335736518510430
   PubMed Web of Science ®Google Scholar
• PeekLJMiddaughCRBerklandCNanotechnology in vaccine deliveryAdv Drug Deliv Rev200860891592818325628
   PubMed Web of Science ®Google Scholar
• VyasTKShahLAmijiMMNanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sitesExpert Opin Drug Deliv20063561362816948557
   PubMedGoogle Scholar
• GuoPRNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapyJ Nanosci Nanotechnol20055121964198216430131
   PubMed Web of Science ®Google Scholar
• Pedziwiatr-WerbickaEFerencMZaborskiMGabaraBKlajnertBBryszewskaMCharacterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotidesColloids Surf B Biointerfaces201183236036621190815
   PubMed Web of Science ®Google Scholar
• LeeCCMacKayJAFréchetJMJSzokaFCDesigning dendrimers for biological applicationsNat Biotechnol2005231517152616333296
   PubMed Web of Science ®Google Scholar
• ChraiSSMurariRAhmadILiposomes: A reviewPharmaceut Tech2002262834
   Google Scholar
• KwonGSForrestMLAmphiphilic block copolymer micelles for nanoscale drug deliveryDrug Develop Res2006671522
   Web of Science ®Google Scholar
• CroySKwonGPolymeric micelles for drug deliveryCurr Pharm Des2006124669468417168771
   PubMed Web of Science ®Google Scholar
• ZhangJLiSLiXPolymeric nano-assemblies as emerging delivery carriers for therapeutic applications: A review of recent patentsRecent Pat Nanotechnol2009322523119958285
   PubMed Web of Science ®Google Scholar
• Bekkara-AounallahFGrefROthmanMNovel PEGylated nanoassemblies nade of self-assembled squalenoyl nucleoside analoguesAdv Funct Mater20081837153725
   Web of Science ®Google Scholar
• CouvreurPStellaBReddyLHSqualenoyl nanomedicines as potential therapeuticsNano Lett200662544254817090088
   PubMed Web of Science ®Google Scholar
• MasonTGWilkingJMelesonKChangCGravesSNanoemulsions: Formation, structure, and physical propertiesJ Phys Condens Mat200618R635R666
   Web of Science ®Google Scholar
• AZoNanoNanocapsules and dendrimers – Properties and future applications Available from: http://www.azonano.com/article.aspx?ArticleID=1649Accessed December 2, 2011
   Google Scholar
• TorchilinVPNanoparticulates as Drug CarriersLondon, UKImperial College Press2006xxix724.516
   Google Scholar
• BawaRNanopharmaceuticals: nanopharmaceuticalsEur J Nanomed201033440
   Google Scholar
• FuAGuWBoussertBSemiconductor quantum rods as single molecule fluorescent biological labelsNano Lett2006717918217212460
   PubMed Web of Science ®Google Scholar
• LiongMLuJKovochichMXiaTMultifunctional inorganic nanoparticles for imaging, targeting, and drug deliveryACS Nano20082588989619206485
   PubMed Web of Science ®Google Scholar
• LeeJELeeNKimHUniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug deliveryJ Am Chem Soc2010132255255720017538
   PubMed Web of Science ®Google Scholar
• LawWCMahajanSDKopwitthayaAGene silencing of human neuronal cells for drug addiction therapy using anisotropic nanocrystalsTheranostics20122769570422896771
   PubMed Web of Science ®Google Scholar
• KreuterJNanoparticulate systems for brain delivery of drugsAdv Drug Deliv Rev200147658111251246
   PubMed Web of Science ®Google Scholar
• ElsabahyMWooleyKLDesign of polymeric nanoparticles for biomedical delivery applicationsChem Soc Rev20124172545256122334259
   PubMed Web of Science ®Google Scholar
• LiuLLawWCYongKTMultimodal imaging probes based on Gd-DOTA conjugated quantum dot nanomicellesAnalyst201113691881188621373688
   PubMed Web of Science ®Google Scholar
• DingHYongKTRoyIGold nanorods coated with multilayer poly-electrolyte as contrast agents for multimodal imagingJ Phys Chem C200711112552
   Web of Science ®Google Scholar
• DorfsDKrahneRFalquiAMannaLGianniniCZanchetDAndrewsDLScholasGDWiederrechtGPComprehensive Nanoscience and TechnologyAmsterdam, The NetherlandsAcademic Press2011219
   Google Scholar
• CaiWShinDWChenKPeptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjectsNano Lett2006666916608262
   PubMed Web of Science ®Google Scholar
• HuRYongKTRoyIFunctionalized near-infrared quantum dots for in vivo tumor vasculature imagingNanotechnology2010211414510520234074
   PubMed Web of Science ®Google Scholar
• AlamMIBegSSamadAStrategy for effective brain drug deliveryEur J Pharm Sci201040538540320497904
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCNanoparticle-based vaginal drug delivery systems for HIV preventionExpert Opin Drug Deliv201071374820017659
   PubMed Web of Science ®Google Scholar
• DouHGrotepasCBMcMillanJMMacrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDSJ Immunol2009183166166919535632
   PubMed Web of Science ®Google Scholar
• NowacekASMillerRLMcMillanJNanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug deliveryNanomedicine (Lond)20094890391719958227
   PubMed Web of Science ®Google Scholar
• DashPKGendelmanHERoyULong-acting NanoART elicits potent antiretroviral and neuroprotective responses in HIV-1 infected humanized miceAIDS7202012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• ShaikNPanGElmquistWFInteractions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitorsJ Pharm Sci200897125421543318393290
   PubMed Web of Science ®Google Scholar
• NevesJDAmijiMMBahiaBFSarmentoBNanotechnology-based systems for the treatment and prevention of HIV/AIDSAdv Drug Deliv Rev20106245847719914314
   PubMed Web of Science ®Google Scholar
• KadiuINowacekAMcMillanJGendelmanHEMacrophage endocytic trafficking of antiretroviral nanoparticlesNanomedicine (Lond)20116697599421417829
   PubMed Web of Science ®Google Scholar
• ShegokarRSinghKKSurface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluationInt J Pharm2011421234135221986114
   PubMed Web of Science ®Google Scholar
• BalkundiSNowacekASRoyUMartinez-SkinnerAMcMillanJGendelmanHEMethods development for blood borne macrophage carriage of nanoformulated antiretroviral drugsJ Vis Exp201046 pii246021178968
   PubMedGoogle Scholar
• GuptaUJainNKNon-polymeric nano-carriers in HIV/AIDS drug delivery and targetingAdv Drug Deliv Rev2010624–547849019913579
   PubMed Web of Science ®Google Scholar
• MamoTMosemanEAKolishettiNSalvador-MoralesCEmerging nanotechnology approaches for HIV/AIDS treatment and preventionNanomedicine (Lond)20105226928520148638
   PubMed Web of Science ®Google Scholar
• BorgmannKRaoKSLabhasetwarVGhorpadeAEfficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neuronsAIDS Res Hum Retroviruses201127885386221175357
   PubMed Web of Science ®Google Scholar
• DestacheCJBelgumTGoedeMShibataABelshanMAAntiretroviral release from poly (DL-lactide-co-glycolide) nanoparticles in miceJ Antimicrob Chemother201065102183218720729545
   PubMed Web of Science ®Google Scholar
• SaiyedZMGandhiNHNairMPMagnetic nanoformulation of azidothymidine 5′-triphosphate for targeted delivery across the blood-brain barrierInt J Nanomedicine72010515716620463931
   PubMed Web of Science ®Google Scholar
• RamanaLNSethuramanSRangaUKrishnanUMDevelopment of a liposomal nanodelivery system for nevirapineJ Biomed Sci2010175720624325
   PubMed Web of Science ®Google Scholar
• ChengYLiDJiBShiXGaoHStructure-based design of carbon nanotubes as HIV-1 protease inhibitors:atomistic and coarse-grained simulationsJ Mol Graph Model201029217117720580296
   PubMed Web of Science ®Google Scholar
• MahajanSDLawWCAalinkeelRNanoparticle-mediated targeted delivery of antiretrovirals to the brainMethods Enzymol20125094364
   Web of Science ®Google Scholar
• MichaletXPinaudFFBentolilaLAQuantum dots for live cells, in vivo imaging, and diagnosticsScience200530753854415681376
   PubMed Web of Science ®Google Scholar
• PrasadPNIntroduction in BiophotonicsNew York, NYWiley2003
   Google Scholar
• PrasadPNNanophotonicsNew York, NYWiley2004
   Google Scholar
• MahajanSDRoyIXuGEnhancing the delivery of anti retroviral drug “Saquinavir” across the blood brain barrier using nanoparticlesCurr HIV Res20108539640420426757
   PubMed Web of Science ®Google Scholar
• MahajanSDReynoldsJLAalinkeelREnhancing the transversing efficiency and efficacy of the anti retroviral drug “saquinavir” using nanotechnology: Implications for nanotherapeutics in neuro-AIDS. HIV Persistance during TherapyFourth International WorkshopDecember 2009Global Antiviral Journal2009524546
   Google Scholar
• XuLLiuYChenZSurface-engineered gold nanorods: Promising DNA vaccine adjuvant for HIV-1 treatmentNano Lett2282012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• KalkanidisMPieterszGAXiangSDMethods for nano-particle based vaccine formulation and evaluation of their immunogenicityMethods2006401202916997710
   PubMed Web of Science ®Google Scholar
• WangXUtoTAkagiTAkashiMBabaMPoly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccineJ Med Virol2008801111918041033
   PubMed Web of Science ®Google Scholar
• TangSHewlettINanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigenJ Infect Dis2010201Suppl 1S59S6420225948
   PubMed Web of Science ®Google Scholar
• LeeKBKimE-YMirkinCAWolinskySMThe use of nanoarrays for highly sensitive and selective detection of human immunodeficiency virus type 1 in plasmaNano Lett200441018691872
   Web of Science ®Google Scholar
• de FougerollesAVornlocherHPMaraganoreJLiebermanJInterfering with disease: a progress report on siRNA-based therapeuticsNat Rev Drug Discov20076644345317541417
   PubMed Web of Science ®Google Scholar
• AignerADelivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivoJ Biomed Biotechnol200647165917057369
   PubMedGoogle Scholar
• HiguchiYKawakamiSHashidaMStrategies for in vivo delivery of siRNAs: recent progressBio Drugs2010243195205
   Google Scholar
• RavinaMPaolicelliPSeijoBSanchezAKnocking down gene expression with dendritic vectorsMini Rev Med Chem2010101738620380642
   PubMed Web of Science ®Google Scholar
• BuxtonDBNanomedicine for the management of lung and blood diseasesNanomedicine (Lond)20094333133919331540
   PubMed Web of Science ®Google Scholar
• de MartimpreyHVauthierCMalvyCCouvreurPPolymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNAEur J Pharm Biopharm200971349050418977435
   PubMed Web of Science ®Google Scholar
• de FougerollesARDelivery vehicles for small interfering RNA in vivoHum Gene Ther200819212513218257677
   PubMed Web of Science ®Google Scholar
• ToubNMalvyCFattalECouvreurPInnovative nanotechnologies for the delivery of oligonucleotides and siRNABiomed Pharmacother200660960762016952435
   PubMed Web of Science ®Google Scholar
• BonoiuACMahajanSDDingHNanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neuronsProc Natl Acad Sci U S A2009106145546555019307583
   PubMed Web of Science ®Google Scholar
• ZhouJNeffCPLiuXSystemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized miceMol Ther201119122228223821952167
   PubMed Web of Science ®Google Scholar
• ZhouJShuYGuoPSmithDDRossiJJDual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibitionMethods201154228429421256218
   PubMed Web of Science ®Google Scholar
• MahajanSDAalinkeelRReynoldsJLNanotherapeutics using an HIV-1 poly A and transactivator of the HIV-1 LTR-(TAR-) specific siRNAPatholog Res Int2011201171913921660279
   PubMedGoogle Scholar
• JiménezJLClementeMIWeberNDCarbosilane dendrimers to transfect human astrocytes with small interfering RNA targeting human immunodeficiency virusBio Drugs2010245331343
   Google Scholar
• GonzaloTClementeMIChoncoLGene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery methodChem Med Chem20105692192920414916
   PubMed Web of Science ®Google Scholar
• BonoiuAMahajanSDYeLMMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrierBrain Res2009128214215519477169
   PubMed Web of Science ®Google Scholar
• KimSSSubramanyaSPeerDShimaokaMShankarPAntibody-mediated delivery of siRNAs for anti-HIV therapyMethods Mol Biol201172133935321431696
   PubMedGoogle Scholar
• LetvinNLProgress toward an HIV vaccineAnnu Rev Med20055621322315660510
   PubMed Web of Science ®Google Scholar
• MallipeddiRRohanLCProgress in antiretroviral drug delivery using nanotechnologyInt J Nanomedicine2010553354720957115
   PubMed Web of Science ®Google Scholar
• KuoYCLeeCLMethylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrierColloids Surf B Biointerfaces201290758222024400
   PubMed Web of Science ®Google Scholar
• das NevesJMichielsJAriënKKPolymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirinePharm Res20122961468148422072053
   PubMed Web of Science ®Google Scholar
• KuoYCChungCYSolid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavirColloids Surf B Biointerfaces201188268269021865017
   PubMed Web of Science ®Google Scholar
• KuoYCYuHWPolyethyleneimine/poly-(γ-glutamic acid)/poly (lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drugColloids Surf B Biointerfaces201188115816421764569
   PubMed Web of Science ®Google Scholar
• YangLChenLZengRSynthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl- 5′-O-d4T monophosphate conjugateBioorg Med Chem201018111712319959368
   PubMed Web of Science ®Google Scholar
• DestacheCJBelgumTChristensenKShibataASharmaADashACombination antiretroviral drugs in PLGA nanoparticle for HIV-1BMC Infect Dis2009919820003214
   PubMed Web of Science ®Google Scholar
• BaertLvan’t KloosterGDriesWDevelopment of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatmentEur J Pharm Biopharm200972350250819328850
   PubMed Web of Science ®Google Scholar
• WanLZhangXPooyanSOptimizing size and copy number for PEG-FMLF (n-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophagesBioconjug Chem2008191283818092743
   PubMed Web of Science ®Google Scholar
• KaurCDNaharMJainNKLymphatic targeting of zidovudine using surfaceengineered liposomesJ Drug Target2008161079880519005941
   PubMed Web of Science ®Google Scholar
• DouHMoreheadJDestacheCJLaboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophagesVirology2007358114815816997345
   PubMed Web of Science ®Google Scholar